In mammals, sex is determined by the Y chromosome, which encodes a testis-determining factor (TDF). This factor causes the undifferentiated embryonic gonads to develop as testes rather than ovaries. The testes subsequently produce the male sex hormones that are responsible for all male sexual characteristics. In 1990, the sex-determining gene, TDF, was identified and termed SRY in humans (Sry in mice). It encodes a protein containing a high mobility group (HMG) motif, which confers the ability to bind and to bend DNA. Genetic evidence supporting SRY as TDF came from the observation of a male phenotype in XX mice transgenic for a small genomic fragment containing Sry, and from the study of XY sex-reversed individuals who harbor de novo mutations in the SRY coding sequence. Other non-Y-linked genes involved in sex determination were subsequently found by genetic analysis of XY sex-reversed patients not explained by mutations in SRY. These genes are WT1, SF1, DAX1, and SOX9. A regulatory cascade hypothesis for mammalian sex determination, proposing that SRY represses a negative regulator of male development, was recently supported by observation of mice that expressed a DAX1 transgene and developed as XY sex-reversed females. The role of some sex-determining genes, such as DAX1 and SF1, in the development of the entire reproductive axis, a functionally integrated endocrine axis, leads to a new concept. Normal sexual development may result from the functional and developmental integration of a number of different genes that play roles in sex determination, sexual differentiation, and sexual behavior.
Sex determination orients development toward sexually dimorphic individuals, which in most species are of male or female phenotype. Once this developmental decision is made, formation of male or female characteristics takes place, which is sexual differentiation.
In mammals, modern concepts of sexual development were established by Alfred Jost (1, 2) . He castrated rabbit fetuses early in development and reimplanted them in the uterus. All animals were female at birth. Jost concluded that the presence or absence of the testes was critical to sex determination, which was therefore equivalent to testis determination. According to this conceptual framework, testis development corresponds to the sex determination step. Once testes are formed, they produce two major hormonal effectors, testosterone and anti-Mü llerian hormone (AMH, also known as MIS, Mü llerian-inhibiting substance), allowing sexual differentiation to take place. Testosterone is responsible for the development of the epidydimis, the vas deferens, the seminal vesicles, and, via 5␣-dihydrotestosterone, the penis and the scrotum. AMH causes the regression of the Mü llerian ducts, which, in fe-males, develop into Fallopian tubes, uterus, and cervix. In 1959, with the description of the karyotype of patients with Turner syndrome (45, X females) (3) and Klinefelter syndrome (47, XXY males) (4), the critical role of the Y chromosome in sex determination was established. If there was a gene responsible for sex determination, it would encode a testis-determining factor (TDF) which would have to be localized on the Y chromosome. These concepts proved correct and led, in 1990, to the identification of TDF, named SRY (Sex-determining Region, Y chromosome gene) on the short arm of the Y chromosome (5) . The molecular era of sexual development was beginning.
Several genes playing a role in sex determination were subsequently identified. The observation that their profiles of expression are not restricted to the gonads, but extend to other organs involved in reproduction, is now leading to a new concept. Sexual development is not limited to normal gonad differentiation: the formation of a fully sexually developed embryo requires the presence of normally functioning pituitary, hypothalamus, and adrenals. These organs are physiologically integrated in a functional axis, referred to as the reproductive axis. Sexual dimorphism can therefore be viewed as the result of the functional and developmental integration of a number of different genes.
GENES INVOLVED IN SEX DETERMINATION

SRY: The Primary Signal for Mammalian Sex Determination
Identification of SRY. Most of the known sex determination genes were identified by positional cloning, using the molecular anomalies present in rare sex-reversed patients. These individuals have a discordance between their phenotypic and genotypic sex. They are XY females with pure gonadal dysgenesis, XX males, or XX true hermaphrodites. XY females with pure gonadal dysgenesis have normal female genitalia, a well-developed uterus, and streak gonads composed of fibrous tissue. Classic XX males have normal male genitalia, no Mü llerian structures, and small azoospermic testes. XX males may also present with hypospadias or sexual ambiguity. XX true hermaphrodites have sexual ambiguity and persistence of some Mü llerian structures, and are defined pathologically by the presence of ovarian and testicular tissue in their gonads.
In 1966, Ferguson-Smith hypothesized that these sex-reversed patients may arise because of an abnormal exchange of genetic material between the X and Y pseudoautosomal regions during male meiosis (6) . If such an event occurred with exchange of chromosomal material involving a Y-specific fragment containing TDF and a portion of the X chromosome, it could give rise to a 46, XX male or a hermaphrodite carrying TDF, or, in the reciprocal product, to a 46, XY female with a deletion of TDF (Fig. 1 ). This hypothesis proved correct for most XX males and a minority of XX hermaphrodites and XY females. More importantly, this hypothesis allowed investi- gators to search successfully for TDF. Y-specific genetic markers revealed the presence and defined the size of Y material translocated to an X chromosome in XX male patients. The minimum portion of the Y chromosome necessary to give rise to a male phenotype in an XX individual was identified in 1989 as a 35-kb fragment adjacent to the pseudoautosomal boundary (7) . In this TDF region, the SRY gene was identified.
SRY is TDF. Several characteristics made SRY an excellent candidate for the sex-determining gene TDF: its conservation in mammals; its localization; its capacity to bind DNA (8); and its appropriate profile of expression in the murine genital ridges from E10.5 to E12.5, immediately prior to the appearance of the seminiferous tubules (9) . However, the definitive evidence equating SRY with TDF is genetic. Point mutations in the SRY open-reading frame were identified in XY females with pure gonadal dysgenesis (10 -21) (Fig. 2) . A single base pair change in SRY changes the fate of the bipotential gonad of an XY fetus from testicular into ovarian development. The other genetic evidence equating SRY and TDF is that the phenotype of XX mice transgenic for a 14-kb fragment containing the murine Sry is male (22) .
Biochemical Properties of SRY
SRY has DNA-binding properties that are mediated by a high mobility group (HMG) motif. HMGbox-containing proteins may be classified into two groups. The first one binds three-dimensional DNA structures, such as four-way junctions, without sequence specificity. The other, which includes SRY, is, in addition, able to recognize DNA with a sequence-specific requirement (23) . SRY binds with a similar affinity to its linear consensus sequence (AA-CAATG, in humans) (24) and to four-way junctions (25) . SRY belongs to a family of HMG-box proteins named SOX (Sry box), binding to the same consensus DNA target as SRY.
The localization of the vast majority of SRY mutations within the HMG-box suggests that it has a crucial role for SRY activity. At this time, only a single de novo mutation has been described outside of the HMG box, leading to the deletion of the 41 C-terminal amino acids in an XY female patient (20) . The SRY C-terminal region was recently shown to bind a PDZ protein named SIP-1 (26) .
Most of the mutations found in SRY occur de novo. However, there are several examples of familial cases of XY sex reversal where the patient and her father carry the same sequence variant in SRY (12, (27) (28) (29) . The incomplete penetrance of these mutations may be caused by an alteration of SRY activity such that it is above or below the critical threshold level, or by interaction between the SRY variant and different alleles of a non-Y-linked locus (27) . One of these familial mutations is found 5Ј to the region coding for the HMG box in SRY (29) .
The HMG domain of SRY is also responsible for altering the geometry of DNA upon binding, suggesting a transcriptional regulatory role. This DNAbending activity is required for normal SRY function, since some mutations present in XY female patients affect mostly the bending rather than the binding property of SRY (30) .
The physiological target gene for SRY remains unclear, as well as the function of the SRY target
FIG. 2.
Mutations in SRY open-reading frame described in XY females with pure gonadal dysgenesis. X refers to nonsense mutations. FS refers to frameshift mutations. Asterisks refer to familial mutations. and whether its complex transcriptional modulation is repression, activation, or both. An activation role was demonstrated in vitro for murine Sry, but a repressor activity was found with human SRY (31) .
SRY and Human Sex Reversal
Various molecular studies of sex-reversed patients show that SRY mutations are found in only 25% of XY females with pure gonadal dysgenesis (14) . SRY is present in only 10% of XX males with sexual ambiguities, 10% of XX true hermaphrodites, and 90% of XX males without sexual ambiguities (32) .
The phenotypic variability observed in XX sexreversed patients carrying a normal SRY gene, from normal male to ambiguous true hermaphrodite, may be explained by the differential inactivation of the X chromosome carrying SRY. The findings in XX sexreversed patients suggest that increased SRY expression is statistically associated with a more masculinized phenotype. It was, however, shown that a completely normal male phenotype could be present in an XX individual with no Y sequences including SRY (33) . The molecular genetic findings in sexreversed patients suggest that SRY is not the only sex-determining gene and that other genes are needed for normal male development.
DSS: X-LINKED SWITCH BETWEEN MALE AND FEMALE DEVELOPMENT
In 1994, a new mechanism, different from mutations in SRY, was shown to be responsible for XY sex reversal (34, 35) . XY individuals who have duplication of a 160-kb critical region of Xp21.3 develop as phenotypic females or with ambiguous genitalia (35) . This region was named DSS for dosage-sensitive sex-reversal. Since 47,XXY patients (Klinefelter syndrome), with two copies of Xp21.3, are male, it would appear that the DSS locus is normally subject to X-inactivation.
The locus for adrenal hypoplasia congenita (AHC), an inherited disorder of the development of the adrenal cortex, also maps to Xp21.3 and is contained within the 160-kb DSS critical region. Using positional cloning techniques, the gene for AHC was identified (36, 37) , and since it was localized within the DSS locus, this gene was named DAX1 (DSS-AHC on the X chromosome, gene 1). It encodes a member of the nuclear hormone receptor superfamily, based on the presence of a conserved region in its carboxy-terminus typical of the ligand-binding domain of other members of the superfamily. DAX1 is an unusual member of the superfamily, since its N-terminus does not resemble a typical DNA-binding domain, but is composed of a novel structure containing 3.5 repeats of 65-67 amino acids that may be organized as two zinc finger motifs. Such a structure is present in only one other protein, the short heterodimer partner (SHP) (38) . Although no physiological target for DAX1 is known, DAX1 binds to single-strand hairpin DNA structures and has been shown to act as a transcriptional repressor (39) .
DAX1 is a candidate for a role in sex determination. It is localized within the small critical region for dosage-sensitive sex reversal (36, 37) , has structural features and biochemical properties characteristic of a transcription factor (40) , and is expressed in the genital ridges at the critical period for sex determination (41) . DAX1 is also expressed along the entire reproductive axis, in the hypothalamus, the pituitary, and the adrenals (37, 42) . The effects on the hypothalamus and pituitary may account for the hypogonadotropic hypogonadism observed in AHC patients with DAX1 mutations (43) . Testicular histology of patients with DAX1 mutations revealed an absence of germ cells and an immaturity of Sertoli cells, suggesting a role of DAX1 in Sertoli cell function (44) . Since XY patients with DAX1 mutations are male and not sex reversed, it is possible that DAX1 plays a role in ovarian development. Detailed expression studies provide additional evidence supporting this hypothesis (41) . In the fetal mouse, Dax1 is first expressed at E11.5 in both sexes, which in males corresponds to the peak of expression of Sry and to the first signs of testis differentiation. The expression of Dax1 becomes sexually dimorphic at E12.5, when it is turned off in the testis but remains expressed in females. These observations are consistent with DAX1 being DSS and with DAX1 playing a role in the switch between male and female genetic pathways. DAX1 expression may be inhibited in testicular tissue, so that it does not interfere with testicular formation. The persistence of DAX1 expression in females is consistent with a role in ovarian formation. When DAX1 is present in a double dose in an XY individual with a tandem duplication of the DSS region, the inhibition of DAX1 expression may be incomplete, allowing initiation of ovarian development and interfering with testis development, therefore leading to XY sex reversal.
What would inhibit DAX1 expression or antagonize its action in males? Transgenic experiments in which XY mice carry extra copies of Dax1 suggest that Sry may play this role (45) . Mice with expressed Dax1 transgenes develop as XY sex-reversed females when a Mus musculus domesticus Poschiavinus strain, the Y chromosome of which is known to be "weak" probably because of low expression of Sry (45) , is used. When a Mus musculus musculus strain is used, no sex reversal is observed. These results suggest that DAX1 may antagonize the action of Sry. The absence of sex reversal in mice carrying a "regular" Y chromosome may be caused not only by the nature of the model system but also by the fact that sex-determination mechanisms are evolving rapidly at the molecular level (46; M. Patel, manuscript in preparation), or by the presence of one or more additional genes within the DSS locus acting in synergy with DAX1.
A GENETIC MODEL FOR MAMMALIAN SEX DETERMINATION
The evidence presented above that SRY and DAX1 may act interdependently and, in some sense, antagonistically is consistent with a previously proposed model of sex determination based on the analysis of sex reversal in humans (47, 48) . The pattern of inheritance of XX sex reversal in familial cases of XX males and XX true hermaphrodites, who carry no Y chromosome fragment including SRY, is most compatible with recessive transmission. The simplest way of interpreting these familial cases would be to hypothesize the existence of a single locus, termed Z, whose mutant recessive allele would confer a male phenotype (Fig. 3) (48) . XX individuals who are Z Ϫ /Z Ϫ homozygotes would develop as males. In this model, where XX sex reversal is a recessive trait, XX maleness would be caused by a loss of function at the Z locus, which is opposite the traditional view of XX sex reversal without SRY, and is usually considered to be caused by a gain-of-function mutation (49) . In order to explain the mechanisms of the recessive mode of inheritance of XX males without SRY, Z would function as an inhibitor of malespecific genes and the function of SRY would be to antagonize the activity of Z. XY females with a normal SRY can also be explained by this model. They may carry a mutation in Z, termed Z i , which would render Z insensitive to SRY action. The observation of XY females with a DSS duplication is consistent with this hypothesis, if we assume that Z is equivalent to DSS or DAX1. In these patients, the dose of SRY would not be high enough to antagonize the increased DAX1 activity, the double dose of which would therefore inhibit testicular development despite the presence of a normal SRY gene expressed at normal levels.
AUTOSOMAL GENES INVOLVED IN SEX DETERMINATION
Genes Required for Early Gonadal Development
The Wilms tumor gene, WT1, initially identified as an oncogene responsible for a pediatric kidney tumor, was shown to be involved in early gonadal development. WT1 expression pattern studies re-
FIG. 3. Proposed model for mammalian sex determination:
SRY may antagonize Z, an inhibitor of male-specific genes (modified from McElreavey et al., 14) . (A) In normal XY males, SRY antagonizes the function of Z, an inhibitor of male-specific genes, which remain on, leading to a male phenotype. (B) In normal XX females, SRY is absent. Z inhibits male-specific genes, which are turned off. Consequently, female development occurs. (C) In XX males lacking SRY, it is proposed that the Z gene is defective, with a Z Ϫ /Z Ϫ homozygous mutation. Male-specific genes are therefore not inhibited by Z and remain on. A male phenotype subsequently develops. (D) In XY females carrying a wild-type SRY, it is proposed that Z carries a mutation (Z i ) rendering it insensitive to the inhibition by SRY. Z inhibits male-specific genes and a female phenotype develops. (E) In XY females with a DSS duplication, it is proposed that Z may be DSS. SRY would be unable to antagonize a double dose of DSS. The remaining active dose of DSS would inhibit male-specific genes and turn them off. A female phenotype would therefore develop.
vealed that it is expressed at E9 in male and female genital ridges (50) . Moreover, knockout mice homozygous for the WT1 null mutation have kidney and gonadal agenesis (51) . The absence of gonads is caused by gonad degeneration during embryogenesis, suggesting a role of WT1 in the maintenance of gonadal development. Finally, mutations in WT1 were identified in patients with Denys-Drash syndrome and Frasier syndrome, who have renal failure and sexual ambiguity, with the additional occurrence of Wilms tumor in those with Denys-Drash syndrome (52) (53) (54) . These observations suggest a role of WT1 in gonad development.
Steroidogenic Factor 1 (SF1) is an orphan nuclear hormone receptor that was initially shown to be a regulator of the expression of cytochrome P450 steroid hydroxylases (55) . SF1 has the same profile of expression as DAX1 (42) . It is expressed in the adrenal cortex, testis, ovary, hypothalamus, and pituitary. In gonads, SF1 is expressed as early as E9 in the mouse, then is turned off at E12.5 in females, but continues to be expressed in male Sertoli cells (56) . Disruption of SF1 in the mouse results in gonadal and adrenal agenesis, resulting in postnatal death by adrenal insufficiency (57) . Like WT1, SF1 seems to be involved in the early development and the maintenance of gonadal tissue, since there is evidence of apoptosis in the gonads of SF1 knockout mice. An SF1-response element was found in the DAX1 promoter (58, 59) and it was shown that SF1 upregulates the expression of DAX1 in an adrenocortical carcinoma cell line (60) . There is also protein-protein interaction between DAX1 and SF1 of unknown physiological significance (61) . In addition, it was recently shown that WT1 antagonizes DAX1 inhibition of SF1-mediated transactivation (62) . SF1 was also shown to regulate MIS via an SF1 response element present in its promoter (63) . The fact that SF1 expression declines only in female gonads suggests that SF1 may play a major role in the control of Mü llerian duct regression.
Another autosomal gene involved in sex determination is a member of the SOX family, named SOX9. Point mutations in SOX9 are associated with campomelic dysplasia (64, 65) , a congenital skeletal malformation syndrome in which a majority of XY patients are XY females with pure gonadal dysgenesis (66) . SOX9 therefore is involved in both chondrogenesis and gonad development. Table 1 summarizes the characteristics of the major genes involved in sex determination and Fig. 4 shows a proposed model of how they may interact with each other.
Other Autosomal Candidate Genes
Two other genomic regions are candidates for roles in sex determination. The 9p24 band is implicated by breakpoints in patients with XY sex reversal (67) (68) (69) . Recently, DMT1, a human homologue of dsx (doublesex), a major regulatory gene involved in Caenorhabditis elegans sex determination, was identified and localized on the distal short arm of chromosome 9 (70) . DMT1 therefore may be a human sex determination candidate gene. Chromosome 10q deletions are also found in XY sex-reversed patients (71) . A recent report of a 10q25 deletion in an XY female may have reduced the critical interval on this chromosome (72). 
SEXUAL DEVELOPMENT: A FUNCTIONALLY AND DEVELOPMENTALLY INTEGRATED SYSTEM
Normal sexual development requires not only normal gonadal differentiation but also normal development of the entire hypothalamic-pituitary-adrenal-gonadal axis, referred to as the reproductive axis. Patients with hypogonadotropic hypogonadism caused by a functional defect in either the hypothalamus or the pituitary may present at birth with a micropenis and undescended testes. The reproductive axis is a functional endocrine axis, with hormonal regulation and feedback loops. GnRH neurons play a role in the secretion of LH and FSH by the pituitary, which in turn induce the secretion of testicular and ovarian hormones. It is striking that some genes, such as DAX1 and SF1, are expressed and play a major developmental role at all levels of this reproductive axis. SF1, in addition, is involved not only in the development of this axis, but also in its function, since it regulates the expression of adrenal steroid hydroxylases and the expression of LH and FSH (55, 73, 74) . This is a new concept in developmental biology, linking developmental mechanisms with ongoing physiological function.
Sexual development represents an example of functional and developmental integration. This integration could be a more general mechanism in mammalian development. For instance, the role of thyroid transcription factor TTF-2, a forkhead protein, in the development of both thyroid and pituitary (75) could represent another example of such integration.
CONCLUSION
Only a limited number of genes are known to be important in mammalian sex determination. The molecular and cellular mechanisms of action of these genes are mostly not understood. Biochemical studies as well as transgenic animal experiments will provide insight into their function. These investigations will also lead to the discovery of other genes in the genetic cascade of sex determination. Finally, the molecular understanding of normal sexual development should not be limited to embryogenesis, but should be extended to sexual behavior. This includes the mechanisms leading to induction of puberty at the appropriate time, and the determinants of brain sexual differentiation. The concept of sexual development as an example of functional and developmental integration may be extended to the central nervous system and sexual behavior.
